how many people are on glp-1 drugs in the us Poll: 1 8 Adults Say They've Taken a Drug, Including 4 in 10 of Those with Diabetes and 1 in 4 of Those with Heart Disease The Multi-Sector Impacts of GLP-1RA

Description

Type 2 diabetes increases the risk for androgenetic alopecia, which manifests as thinning and hair loss

Comparison of the phenotype and approach to pediatric vs adult patients with nonalcoholic fatty liver disease

However, there is the potential for DDIs of GLP-1 RAs to occur through their mechanisms of action

GLP-1R agonists regulate various molecular pro-inflammatory mediators, including oxidative stress, cytokine production, immune cell recruitment, glucotoxicity, and lipotoxicity ([50])

What is already known on this topic Concerns exist about a potential association between glucagon-like peptide-1 receptor (GLP-1) agonists and suicidality This has prompted regulatory agencies to conduct comprehensive reviews of this drug class Observational studies investigating this safety concern remain inconclusive